China (Mainland)
Lorcaserin Hydrochloride Weight loss fat raw material CAS NO.846589-98-8
- FOB Price: USD: 50.00-50.00 /Metric Ton Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: T/T,MoneyGram
- Available Specifications:
10(10-20)Metric Ton
- Product Details
Keywords
- Lorcaserin Hydrochloride
- Testosterone Base
- Testosterone Acetate
Quick Details
- ProName: Lorcaserin Hydrochloride Weight loss f...
- CasNo: 846589-98-8
- Molecular Formula: C26H40O3
- Appearance: White powder
- Application: Quick Detail: 1.Place of Origin: Chi...
- DeliveryTime: 7days
- PackAge: Foil bag
- ProductionCapacity: 50000 Kilogram/Week
- Purity: 99
- Storage: Placed in a cool place
- LimitNum: 1 Gram
- Moisture Content: 0.001
- Impurity: 0.001
Superiority
Lorcaserin Hydrochloride
Product Name Lorcaserin HCl Powder
CAS Registry Number 846589-98-8
Molecular Formula C11H14ClNClH
Molecular Weight 232.1525
Purity 99%
Grade Pharmaceutical Grade
Appearance White Crystalline Powder
Details
Lorcaserin Hydrochloride
Product Name Lorcaserin HCl Powder
CAS Registry Number 846589-98-8
Molecular Formula C11H14ClNClH
Molecular Weight 232.1525
Purity 99%
Grade Pharmaceutical Grade
Appearance White Crystalline Powder
Quick Detail:
1.Place of Origin: China
2.CAS No.: 846589-98-8
3.Molecular Formula: C11H15Cl2N
4.Assay: 99%
5.Molecular Weight: 232.1525
6.Appearance: White powder.
Description:
Belviq(Lorcaserin hydrochloride) is an FDA-approved prescription weight-loss medication that, when used with diet and exercise, can help some overweight adults with a weight-related medical problem, or obese adults, lose weight and keep it off. It is not known if BELVIQ when taken with other prescription, over-the-counter, or herbal weight-loss products is safe and effective. It is not known if BELVIQ changes your risk of heart problems, stroke, or death due to heart problems or stroke.
Applications:
Belviq is a serotonin 2C receptor agonist. It hasbeen shown to decrease food consumption and promote satiety by selectivelyactivating serotonin 2C receptors in the brain.
Belviq is specifically indicated as an adjunct to a reduced-calorie diet andincreased physical activity for chronic weight management in clinically obeseadults (BMI of 30 kg/m2 or greater) and overweight adults (BMI of 27 kg/m2 orgreater) with at least one weight-related comorbid condition.
Belviq is supplied as a tablet designed for oral administration. The recommendeddose is one 10mg tablet twice daily. Use of Belviq should be discontinued if 5%weight loss is not achieved by week 12 of treatment.
